René Rückert
Directeur des opérations chez Isarna Therapeutics GmbH
Postes actifs de René Rückert
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Isarna Therapeutics GmbH
 Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Directeur des opérations | 01/01/2019 | - |
| Directeur Technique/Scientifique/R&D | 01/01/2018 | 01/01/2019 |
Historique de carrière de René Rückert
Formation de René Rückert
| Charité - Universitätsmedizin Berlin | Doctorate Degree |
| Warwick Business School | Masters Business Admin |
Statistiques
Internationale
| Allemagne | 3 |
| Royaume-Uni | 2 |
Opérationnelle
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Isarna Therapeutics GmbH
Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Health Technology |
- Bourse
- Insiders
- René Rückert
- Expérience
